Topic Review
The Golgi Associated Retrograde Protein Complex
The Golgi associated retrograde protein complex (GARP) is an evolutionarily conserved component of Golgi membrane trafficking machinery that belongs to the Complexes Associated with Tethering Containing Helical Rods (CATCHR) family.
  • 627
  • 31 Mar 2023
Topic Review
BCR::ABL1-Negative MPN
Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell-derived disorders characterized by uncontrolled proliferation of differentiated myeloid cells. Two main groups of MPN, BCR::ABL1-positive (Chronic Myeloid Leukemia) and BCR::ABL1-negative (Polycythemia Vera, Essential Thrombocytosis, Primary Myelofibrosis) are distinguished. For many years, cytomorphologic and histologic features were the only proof of MPN and attempted to distinguish the different entities of the subgroup BCR::ABL1-negative MPN. World Health Organization (WHO) classification of myeloid neoplasms evolves over the years and increasingly considers molecular abnormalities to prove the clonal hematopoiesis.
  • 358
  • 31 Mar 2023
Topic Review
Getting Sugar Coating Right—Role of Golgi Trafficking Machinery
The Golgi is the central organelle of the secretory pathway and it houses the majority of the glycosylation machinery, which includes glycosylation enzymes and sugar transporters. Correct compartmentalization of the glycosylation machinery is achieved by retrograde vesicular trafficking as the secretory cargo moves forward by cisternal maturation. The vesicular trafficking machinery which includes vesicular coats, small GTPases, tethers and SNAREs, play a major role in coordinating the Golgi trafficking thereby achieving Golgi homeostasis. Glycosylation is a template-independent process, so its fidelity heavily relies on appropriate localization of the glycosylation machinery and Golgi homeostasis. Mutations in the glycosylation enzymes, sugar transporters, Golgi ion channels and several vesicle tethering factors cause congenital disorders of glycosylation (CDG) which encompass a group of multisystem disorders with varying severities.
  • 246
  • 30 Mar 2023
Topic Review
Pathophysiology of Acute Myeloid Leukemia
Acute myeloid leukemia is a cancerous condition that affects hemopoietic stem cells or progenitors and is defined by the stopping of myeloid lineage development and abnormal proliferation.
  • 1.2K
  • 30 Mar 2023
Topic Review
Senescence in Physiological Processes and Age-Related Diseases
Cellular senescence is a physiological mechanism that has both beneficial and detrimental consequences. Senescence limits tumorigenesis, lifelong tissue damage, and is involved in different biological processes, such as morphogenesis, regeneration, and wound healing. 
  • 778
  • 28 Mar 2023
Topic Review
Plasma Membrane Ion Channels on Bone Remodeling
The extracellular milieu is a rich source of different stimuli and stressors. Some of them depend on the chemical–physical features of the matrix, while others may come from the ‘outer’ environment, as in the case of mechanical loading applied on the bones. In addition to these forces, a plethora of chemical signals drives cell physiology and fate, possibly leading to dysfunctions when the homeostasis is disrupted. This variety of stimuli triggers different responses among the tissues: bones represent a particular milieu in which a fragile balance between mechanical and metabolic demands should be tuned and maintained by the concerted activity of cell biomolecules located at the interface between external and internal environments. Plasma membrane ion channels can be viewed as multifunctional protein machines that act as rapid and selective dual-nature hubs, sensors, and transducers.
  • 297
  • 24 Mar 2023
Topic Review
Mechanobiology of Metastasis
The major cause (more than 90%) of all cancer-related deaths is metastasis, thus its prediction can critically affect the survival rate. Metastases are predicted by lymph-node status, tumor size, histopathology and genetic testing. The identification of new potential prognostic factors will be an important source of risk information for the practicing oncologist, potentially leading to enhanced patient care through the proactive optimization of treatment strategies. Mechanobiology, as a branch of biomechanics and/or a branch of biology, has reached a mature stage mainly because of the significant technological and methodological advances at the cellular, subcellular, and molecular levels and the need to disclose the mechanical basis of biology. The application of mechanobiology to medicine (mechanomedicine) may help advance human health and improve diagnostics, treatment, and therapeutics of cancer.
  • 293
  • 23 Mar 2023
Topic Review
Lipid-Based Antioxidant Systems in Photoreceptors and RPE Cells
The retina, a multi-layered nervous structure in the back of the eye, detects light stimuli via specialised primary sensory neurons, named after their morphologies as retinal rods and cones. Rods and cones in vitro may retain their ability to respond to light for several hours by generating an electrical response. However, their viability and long-term operation require the functional interaction with retinal pigment epithelial (RPE) cells and a vascular system with peculiar features, the choroidal capillaries (ChC), whose specific form and shape support its function.
  • 363
  • 20 Mar 2023
Topic Review
Epithelial Stem Cell Innovation
The field of epithelial stem cell development has been irrevocably shaped by the work of American scientist Howard Green, whose breakthroughs in stem cell culture methods translated to therapeutic practice.
  • 391
  • 20 Mar 2023
Topic Review
Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families in Cancer
The structure and dynamics of the neurokinin (NK)-2, NK-3, and calcitonin gene-related peptide (CGRP) receptors are studied together with the intracellular signaling pathways in which they are involved. These peptides play an important role in many cancers, such as breast cancer, colorectal cancer, glioma, lung cancer, neuroblastoma, oral squamous cell carcinoma, phaeochromocytoma, leukemia, bladder cancer, endometrial cancer, Ewing sarcoma, gastric cancer, liver cancer, melanoma, osteosarcoma, ovarian cancer, pancreatic cancer, prostate cancer, renal carcinoma, and thyroid cancer. These peptides are involved in tumor cell proliferation, migration, metastasis, angiogenesis, and lymphangiogenesis.
  • 286
  • 17 Mar 2023
  • Page
  • of
  • 161
Video Production Service